白蛋白结合 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-03-08. Where a claim depends on a specific study, the study is described rather than over-claimed.
The primary target is the GLP-1 receptor, a class B G protein-coupled receptor expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises intracellular cyclic AMP, which potentiates glucose-dependent insulin secretion and lowers glucagon release when blood glucose is elevated. Signalling in the hypothalamus and brainstem is associated with reduced appetite and slower gastric emptying. Because the insulinotropic effect depends on prevailing glucose levels, the hypoglycaemic risk of the peptide alone is described as low in most study settings. The relative contribution of peripheral and central actions remains an active research question.
Large randomised trials in adults with type 2 diabetes and in adults with obesity have reported reductions in body weight and improvements in several cardiovascular risk markers. One outcome trial found a lower incidence of major adverse cardiovascular events in participants with diabetes and established cardiovascular disease. Gastrointestinal effects such as nausea and vomiting are the most frequently reported adverse events and often diminish over time. Changes in lean body mass during weight loss are an area of ongoing investigation. Effects in adolescents and in pregnancy are less well characterised, and current labelling advises against use during pregnancy.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released by intestinal L cells after food intake. The natural hormone acts on pancreatic and central receptors but is degraded within minutes by dipeptidyl peptidase-4 and other peptidases. Semaglutide belongs to the class of long-acting GLP-1 receptor agonists, a group distinguished by structural changes that slow breakdown and extend circulation time. Its development followed earlier short-acting analogues and reflects a general strategy in peptide drug design: preserve receptor activity while blocking proteolytic clearance.
Three structural changes define the molecule. At position 8 an alpha-aminoisobutyric acid residue replaces alanine, which blocks dipeptidyl peptidase-4 cleavage. At position 34 arginine replaces lysine, and at position 26 a lysine carries a C18 fatty diacid attached through a short linker. The fatty chain binds serum albumin, and this albumin association reduces renal filtration and enzymatic attack. The unchanged backbone retains the receptor contacts that produce signalling. The free base has the formula C187H291N45O59 and a molecular weight near 4114 daltons.
Receptor activation follows the canonical Gs pathway: binding increases intracellular cyclic AMP, which promotes protein kinase A activity. In pancreatic beta cells this amplifies glucose-dependent insulin release, so secretion rises when blood glucose is high and changes little when it is low. The same signalling suppresses glucagon release from alpha cells and slows gastric emptying. Receptors in the hypothalamus and brainstem are thought to contribute to reduced appetite and lower energy intake. Which of these effects dominates clinical outcomes remains an area of active study.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Acylated GLP-1 receptor agonist | 31-residue synthetic peptide |
| Molecular formula | C187H291N45O59 | established for the free peptide |
| Appearance | White to off-white powder | as supplied before formulation |
| Solubility | Freely soluble in water | aqueous buffers near neutral pH |
| Typical storage | 2 to 8 degrees Celsius, protected from light | powder and solution forms differ in shelf life |
Serum protein binding dominates the pharmacokinetic profile. The attached chain associates strongly with albumin, shielding the peptide from enzymatic attack and slowing filtration by the kidney. This interaction extends the circulation half-life to roughly one week in humans, which supports weekly administration intervals. An oral version pairs the peptide with an absorption enhancer that transiently alters gastric epithelium, permitting limited uptake; bioavailability by that route is substantially lower than by injection.
Semaglutide belongs to the glucagon-like peptide-1 receptor agonist class, a group of synthetic peptides that imitate an incretin hormone released by intestinal L cells after food intake. Native GLP-1 circulates for only a few minutes because dipeptidyl peptidase-4 cleaves it rapidly. The hormone acts on pancreatic islets, the gastrointestinal tract, and several brain regions. Because the natural peptide is short-lived, development work concentrated on analogues that keep receptor activity while resisting enzymatic breakdown and renal clearance.
The semaglutide sequence is a 31-residue analogue of human GLP-1, altered at three positions relative to the parent hormone. Aminoisobutyric acid replaces alanine at position 8, arginine replaces lysine at position 34, and a lipophilic diacid is attached to lysine 26 through a short linker. These features are reported consistently in the structural literature. The position 8 substitution blocks recognition by dipeptidyl peptidase-4, while the attached chain drives strong, reversible association with a carrier protein in blood.
该分子作为 GLP-1 受体的选择性激动剂发挥作用，受体属于 B 类 G 蛋白偶联受体家族，激活后经 Gs 通路提升细胞内环腺苷酸水平。在胰腺 β 细胞，信号促进葡萄糖依赖性的胰岛素释放，血糖偏低时该作用明显减弱。在胰岛 α 细胞，胰高血糖素分泌受到抑制。中枢神经系统与胃肠道同样存在受体表达，相应信号参与食欲调节以及胃排空速率的降低。
皮下注射后吸收相对缓慢，绝对生物利用度约为百分之八十九，血药浓度峰值通常出现在给药后一到三天。与白蛋白结合使清除减慢，终末半衰期约为一百六十五小时，接近一周。连续给药约四到五周后达到稳态暴露水平。表观分布容积约为每千克零点二五升，血浆蛋白结合率超过百分之九十九。代谢以蛋白水解切割和脂肪二酸侧链的 β-氧化为主，相关产物主要经尿液与粪便排出。
序列层面的改动同时解决了两个问题，即酶解稳定性与肾脏清除速度。天然 GLP-1 在循环中的半衰期仅约两分钟，主要被二肽基肽酶-4 迅速灭活。酰化侧链与白蛋白的可逆结合形成循环储库，使分子缓慢释放并持续激活受体。这种设计思路后来被广泛用于同类长效肽的开发，属于该类药物化学改造的典型范式。
== Electoral system == The president of Venezuela is elected by direct, secret ballot in a single nationwide constituency using plurality voting (first-past-the-post). Elections are organised and supervised by the National Electoral Council (CNE), one of the five constitutionally recognised branches of government, which oversees an automated voting system with electronic machines and paper audit trails. Article 227 of the Constitution sets eligibility criteria for presidential candidates, including being Venezuelan by birth without another nationality, at least 30 years old and with no disqualifying criminal convictions, while Article 229 bars sitting executive vice-presidents, ministers, governors and mayors from running unless they leave office beforehand.
In July 2020, the International Crisis Group (ICG) published an analysis saying that the reason for the decrease in homicides during Bukele's first year in office hypothesized that "quiet, informal understandings" between the government and the gangs. The Salvadoran government denied the ICG's allegations, and the ICG stated that it had no evidence to support the claim. In September 2020, the Salvadoran digital newspaper El Faro accused Bukele's government of conducting secret negotiations with MS-13. According to the El Faro report, the government agreed to grant MS-13 more freedom in prison in exchange for a reduction in homicides it would commit and support for Nuevas Ideas during the 2021 legislative elections. Bukele denied El Faro's allegations, posting photos on Twitter of gang members rounded up in cramped conditions from an April 2020 prison crackdown. On 8 December 2021, the United States Department of the Treasury accused Bukele's government of secretly negotiating with MS-13 and Barrio 18 to lower the country's homicide rate. The department stated that Bukele's government "provided financial incentives" to both gangs to ensure that they would reduce the country's homicide rate and support Nuevas Ideas in the election held earlier that year, echoing El Faro's allegations the year before, and sanctioned Osiris Luna Meza (the general director of penal centers and vice-minister of justice) and Social Fabric Revitalization Unit chair Carlos Marroquín Chica for negotiating with the gangs.
== History == Chloral hydrate was first synthesized by the chemist Justus von Liebig in 1832 at the University of Giessen. Liebig discovered the molecule when a chlorination (halogenation) reaction was performed on ethanol. Its sedative properties were observed by Rudolf Buchheim in 1861, but described in detail and published only in 1869 by Oscar Liebreich; subsequently, because of its easy synthesis, its use became widespread. Through experimentation, physiologist Claude Bernard clarified that the chloral hydrate was hypnotic as opposed to an analgesic. It was the first of a long line of sedatives, most notably the barbiturates, manufactured and marketed by the German pharmaceutical industry. Historically, chloral hydrate was utilized primarily as a psychiatric medication. In 1869, German physician and pharmacologist Oscar Liebreich began to promote its use to calm anxiety, especially when it caused insomnia. Chloral hydrate had certain advantages over morphine for this application, as it worked quickly without injection and had a consistent strength. The compound achieved wide use in both asylums and the homes of those socially refined enough to avoid asylums. Upper- and middle-class women, well-represented in the latter category, were particularly susceptible to chloral hydrate addiction. After the 1904 invention of barbital, the first of the barbiturate family, chloral hydrate began to disappear from use among those with means. It remained common in asylums and hospitals until the Second World War as it was quite cheap.
Sources: en.wikipedia.org
== Further reading == Braver, Lee, (2015) "Coin-Operated Doors and God: A Gnostic Reading of Philip K. Dick's Ubik", Extrapolation 56.1, pp. 83–110. https://doi.org/10.3828/extr.2015.6 Fitting, Peter, (1975) "Ubik and the Deconstruction of Bourgeois SF Archived 2020-08-04 at the Wayback Machine", Science-Fiction Studies # 5, 2:1, pp. 47–54. Lem, Stanislaw, (1975) "Science and Reality in Philip K. Dick's Ubik", A Multitude of Visions, ed. Cy Chauvin, Baltimore; T-K Graphics, pp. 35–9. Pagetti, Carlo, (2003) "Ubik uno e trino" [afterword], Philip K. Dick, Ubik, Roma: Fanucci, pp. 253–66. (in Italian) Proietti, Salvatore, (2006) "Vuoti di potere e resistenza umana: Dick, Ubik e l'epica americana", Trasmigrazioni: I mondi di Philip K. Dick, eds. Valerio Massimo De Angelis and Umberto Rossi, Firenze: Le Monnier, pp. 204–16. (in Italian)
On 26 September, Trump rejected Iran's seven-day ceasefire proposal and expressed doubt that Tehran would eventually comply with his administration's nuclear demands. In a phone interview the following day, Trump said that he still expected more talks with Iran to resume during the week. Trump claimed that Iran "wanted to make a deal," but they "overplayed their hand" by offering conditions that the US "would have maybe agreed to a year ago." By late September 2026, crude oil and petroleum flows through the Strait of Hormuz had recovered to 77% to 80% of pre-war levels, totaling an estimated 13.19 million barrels per day. A US Navy campaign that used armed convoy escorts and unmonitored "dark transits" was responsible for the stabilization of shipping traffic. Iran's own oil and petrochemical exports were severely limited at the same time due to the combined effects of an active US naval blockade and a broad secondary sanctions campaign known as Operation Economic Outcast. This economic contraction drove the Iranian rial to a historic low of 2.5 million rials per U.S. dollar, significantly eroding Iran's primary geopolitical leverage against Washington. Despite the decline in its conventional enforcement capabilities, the IRGC maintained asymmetric tactics, ensuring maritime insurance premiums remained highly elevated. As worries about Iranian retaliation grew, the US military sent two more Patriot missile batteries to Saudi Arabia and Qatar in September 2026 to safeguard vital energy infrastructure.
=== Health and safety === The resins used to create OSB have raised questions about their emission of volatile organic compounds such as formaldehyde, although industry trade groups assert that formaldehyde emissions from North American OSB are "negligible or nonexistent". Urea-formaldehyde is more toxic and should be avoided in home use. Phenol-formaldehyde products are considered to be relatively hazard free. Some newer types of OSB, so-called "new-generation" panels, use isocyanate resins that contain no formaldehyde and are considered nonvolatile when cured. Some manufacturers treat the wood chips with various borate compounds that are toxic to termites, wood-boring beetles, molds, and fungi, but not mammals in applied doses. In 2024, a hotel in Dublin, Ireland, lost its fire safety certificate after an inspection found fault with the composition of OSB in its flooring and walls.
The study of these structures and related self-organized systems is known as "chemobrionics", an emerging interdisciplinary field that integrates the concepts of physics, chemistry, materials science, biology and complex systems science to investigate reaction-diffusion-driven pattern formation. The term chemobrionics derives from "chemo" and the Greek word bruein ("to grow or enlarge"), referring to the osmotically driven growth of chemical gardens and related self-organized inorganic systems.
Sources: en.wikipedia.org
Native GLP-1 is degraded within minutes by dipeptidyl peptidase-4 and neutral endopeptidases. Semaglutide carries a non-natural amino acid at position eight that blocks that cleavage, and a fatty diacid side chain that binds albumin. The result is a much longer duration of action than the native hormone.
The fatty diacid chain associates strongly with serum albumin, which keeps the peptide in circulation and shields it from rapid renal clearance. Bound peptide is released gradually, producing a sustained receptor signal. This mechanism also reduces the peak-to-trough variation seen with shorter-acting analogues.
The balance between peripheral receptor activation and signalling in the central nervous system is not fully resolved. The extent to which slowed gastric emptying accounts for reduced energy intake, compared with direct effects on appetite circuits, is debated. Long-term effects on lean mass and on tissues outside the gut and brain are still under study.
Native GLP-1 is a short-lived peptide cleared within one to two minutes by dipeptidyl peptidase-4 and related enzymes. Semaglutide keeps the receptor-binding backbone but adds substitutions and a lipid chain. These changes block the main cleavage site and allow reversible albumin binding, extending the half-life to roughly 165 hours.